Abstract:The immune system plays a central role in tissue repair and regeneration. Indeed, the immune response to tissue injury is crucial in determining the speed and the outcome of the healing process, including the extent of scarring and the restoration of organ function. Therefore, controlling immune components via biomaterials and drug delivery systems is becoming an attractive approach in regenerative medicine, since therapies based on stem cells and growth factors have not yet proven to be broadly effective in the clinic. To integrate the immune system into regenerative strategies, one of the first challenges is to understand the precise functions of the different immune components during the tissue healing process. While remarkable progress has been made, the immune mechanisms involved are still elusive, and there is indication for both negative and positive roles depending on the tissue type or organ and life stage. It is well recognized that the innate immune response comprising danger signals, neutrophils and macrophages modulates tissue healing. In addition, it is becoming evident that the adaptive immune response, in particular T cell subset activities, plays a critical role. In this review, we first present an overview of the basic immune mechanisms involved in tissue repair and regeneration. Then, we highlight various approaches based on biomaterials and drug delivery systems that aim at modulating these mechanisms to limit fibrosis and promote regeneration. We propose that the next generation of regenerative therapies may evolve from typical biomaterial-, stem cell-, or growth factor-centric approaches to an immune-centric approach.STATEMENT OF SIGNIFICANCE: Most regenerative strategies have not yet proven to be safe or reasonably efficient in the clinic. In addition to stem cells and growth factors, the immune system plays a crucial role in the tissue healing process. Here, we propose that controlling the immune-mediated mechanisms of tissue repair and regeneration may support existing regenerative strategies or could be an alternative to using stem cells and growth factors. The first part of this review we highlight key immune mechanisms involved in the tissue healing process and marks them as potential target for designing regenerative strategies. In the second part, we discuss various approaches using biomaterials and drug delivery systems that aim at modulating the components of the immune system to promote tissue regeneration.

Rebuilding and rebooting immunity with stem cells

Genetically modified immunomodulatory cell-based biomaterials in tissue regeneration and engineering

Immune Reconstitution in the Aging Host: Opportunities for Mechanism-Based Therapy in Allogeneic Hematopoietic Cell Transplantation

Rejuvenating an old immune system

Reprograming the Immune Niche for Skin Tissue Regeneration - from Cellular Mechanisms to Biomaterials Applications.

Rejuvenating aged stem cells: therapeutic strategies to extend health and lifespan

Tissue engineering and cell based therapies, from the bench to the clinic: the potential to replace, repair and regenerate

Potential of Mesenchymal Stem Cells in the Rejuvenation of the Aging Immune System

Twisting Immune Responses for Allogeneic Stem Cell Therapy.

Understanding and Modulating Immunity With Cell Reprogramming

Utilizing Stem Cells to Address Skin Tissue Immune Rejection

Tissue restoration through regenerative biology and medicine

Rejuvenation Strategy for Inducing and Enhancing Autoimmune Response to Eliminate Senescent Cells

Promoting tissue regeneration by modulating the immune system

Regulatory T-Cells: Potential Regulator of Tissue Repair and Regeneration

Stem Cells in Wound Healing: The Future of Regenerative Medicine? A Mini-Review

Basic immunologic study as a foundation for engineered therapeutic development

Restoring aged stem cell functionality: Current progress and future directions

Toward a Better Regeneration Through Implant-Mediated Immunomodulation: Harnessing the Immune Responses.

Harnessing Biomaterials to Amplify Immunity in Aged Mice through T Memory Stem Cells

Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity